TECH & INNOVATION

Anamorelin improve appetite and body mass in patients with cancer anorexia-cachexia

TECH & INNOVATION 09.28.2014 00:59 AM

Phase III trial indicates the drug is safe and well tolerated in advanced non-small cell lung cancer

Afatinib improves progression-free survival in head and neck cancer

09.28.2014 00:51 AM

Second-line afatinib significantly improves progression-free survival in recurrent or metastatic head and neck cancer, Phase III trial shows

Rolapitant reduces nausea and vomiting in Phase III trial

09.28.2014 00:44 AM

Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain.

Many patients excluded from clinical trials due to prior cancer, UTSW study finds

09.28.2014 00:26 AM

DALLAS – Sept. 26, 2014 – Lung cancer clinical trials exclude a substantial proportion of patients due to a history of prior cancer, as shown in an analysis by cancer researchers at UT Southwestern Medical Center.

Cancer during pregnancy: Chemotherapy and radiotherapy are safe for babies, studies show

09.28.2014 00:21 AM

Presentations at ESMO 2014 examine the impact of in-utero exposure to chemotherapy and radiotherapy, the safety of lymph node biopsy in pregnancy, and the outcomes of unplanned pregnancy during cancer treatment

U.S. Territory Comes Under Strict Protection—Species Needing Sanctuary Look To the South Pacific

09.26.2014 22:44 PM

Over its short-lived history, the United States has come to acquire a small list of territories outside of its continental limits. And as it happens some are more well-protected than others.

Brains not recognizing an angry expression

09.26.2014 02:09 AM

Responses of children with attention-deficit/hyperactivity disorder Responses of children with attention-deficit/hyperactivity disorder Inattention, hyperactivity, and impulsive behavior in children with ADHD can result in social problems and they tend to be excluded from peer activities.

Simple blood test could be used as tool for early cancer diagnosis

09.26.2014 02:05 AM

High levels of calcium in blood, a condition known as hypercalcaemia, can be used by GPs as an early indication of certain types of cancer, according to a study by researchers from the universities of Bristol and Exeter.

New genes identified with key role in the development of severe childhood epilepsies

09.26.2014 02:01 AM

In the largest collaborative study so far, an international team of researchers, including scientists from VIB and Antwerp University identified novel causes for severe childhood epilepsies.

Spot on against autoimmune diseases and chronic inflammations

09.26.2014 01:58 AM

Multiple sclerosis, type 1 diabetes and lupus have one thing in common: They are all autoimmune diseases in which the immune cells can no longer differentiate between friend or foe and thus attack the body's own tissue.

Massive weight loss increases risk of complications in body-shaping surgery

09.26.2014 01:56 AM

Patients who lost more than 100 pounds and those who shed weight through bariatric surgery had the highest risk of complications from later surgical procedures to reshape their leaner bodies, a new study from UT Southwestern Medical Center shows.

Pneumonia bacterium leaves tiny lesions in the heart, study finds

09.26.2014 01:53 AM

Three institutions collaborate to develop vaccine to treat infection Three institutions collaborate to develop vaccine to treat infection The long-observed association between pneumonia and heart failure now has more physical evidence, thanks to research in the School of Medicine at The University of Texas Health Science Center at San Antonio.

New study shows that yoga and meditation may help train the brain

09.26.2014 01:49 AM

Groundbreaking research could provide new treatments for people who are paralyzed or have neurodegenerative diseases

Genetic 'instruction set' for antibodies knocks down hepatitis C in mice

09.26.2014 01:41 AM

A triple-punch of antibodies both prevented hepatitis C infection and wiped out the disease after it had established itself in laboratory mice, according to a study led by Princeton University researchers. Instead of delivering the three antibodies directly, the researchers administered a genetic "instruction set" that, once in a cell, developed into antibodies that target the portions of the virus that do not mutate.

NOT ALL HISPANICS ARE THE SAME WHEN IT COMES TO DRINKING

09.26.2014 01:38 AM

Hispanics are often grouped into a single category when it comes to alcohol use. Yet a new Michigan State University study indicates that the risk of alcohol abuse and dependence can vary significantly among different subgroups within the population.

462 463 464 465 466 467 468 469 470

Most Popular

3I/ATLAS: The Truth Behind the Mysterious Interstellar Object Now Targeted by NASA and UN Teams

Hellfire Missile Video Reveals MQ-9 Reapers Being Used for Aerial Combat

Nvidia's Jetson Thor Could Make Humanoids Smarter Than Ever

Cyber Attack on Jaguar and Land Rover Cripples UK Operations: 1 October Earliest Restart as Deliveries Disrupted Worldwide

Avi Loeb Claims 3I/ATLAS May Be Made of Antimatter—'The Most Efficient Fuel'